AP4M1 and glioblastoma: Notably, whilst MU4 sEVs initially lacked FSCN1 and MMP14 in their surfaceome, these two proteins were identified in MU4 sEVs following RT/TMZ treatment, suggesting that these sEVs may exhibit enhanced invadopodia-promoting activity upon interaction with recipient GBM cells.